AGP Picks
View all

Afriplex wins US interest at SupplySide Global 2026

7 hours ago
By AI, Created 12:30 UTC, Nov 17, 2026, AGP -

South African botanical ingredient maker Afriplex says its SupplySide Global 2026 showing in Las Vegas drew strong US interest in its African plant-based ingredients and opened new partnership channels. The response could help the company expand in the world’s largest consumer healthcare market and create more routes for South African manufacturers to reach US buyers.

Why it matters: - Afriplex’s US push could open commercial pathways for South African pharmaceutical, nutraceutical and healthcare companies that struggle to break into the American market on their own. - The strong response to African botanical ingredients suggests there is room in the US for differentiated, science-backed natural ingredients, not just commodity extracts.

What happened: - Afriplex said its participation at SupplySide Global 2026 in Las Vegas was a success and marked a step in its international expansion strategy. - The company used the exhibition to showcase African botanical ingredients to ingredient suppliers, manufacturers, formulators and healthcare stakeholders. - Two products drew the most attention: Kannaspectrum™, a standardized Sceletium tortuosum extract, and Pelargonium S70™, a pharmaceutical-grade Pelargonium sidoides extract for respiratory healthcare applications. - Afriplex also formed new relationships with international industry participants during the event.

The details: - Kannaspectrum™ is standardized to 1% total alkaloids. - Pelargonium S70™ is positioned as an active pharmaceutical ingredient developed from Pelargonium sidoides. - Afriplex said the interest in its products reflects demand for ingredients with defined functionality, consistent quality and documented specifications. - The company’s portfolio spans functional botanical ingredients for wellness products and active pharmaceutical ingredients for more technical applications. - Afriplex’s operating model includes botanical raw material sourcing, extraction, standardization, analytical testing and formulation development. - The company also said its work on Sceletium is supported by relevant bioprospecting arrangements and permits. - Afriplex operates within a pharmaceutical quality framework, including SAHPRA-regulated manufacturing capabilities. - The company also maintains food safety systems relevant to nutraceutical and functional ingredient work. - Its technical infrastructure includes analytical and microbiological testing, product characterization, quality control and stability assessment. - The company’s website is Afriplex's website.

Between the lines: - The exhibition response points to a broader shift in the ingredient market toward functionality, scientific substantiation and market-specific formulation support. - Afriplex is trying to move African botanicals beyond raw-material exports and into standardized, higher-value ingredients that can fit US regulatory and commercial requirements. - The company’s partnership model suggests it wants to be more than an exporter. It wants to be a bridge between South African developers and US distributors, manufacturers and formulators.

What's next: - Afriplex said future commercial opportunities will depend on the relevant US regulatory pathways and on converting exhibition conversations into long-term customer relationships. - The new contacts could lead to distribution deals, collaborative product development and other market-entry partnerships. - Afriplex said it will continue using its US relationships and market intelligence to help South African customers adapt products for international markets.

The bottom line: - SupplySide Global 2026 gave Afriplex a stronger US foothold and a clearer signal that African botanical ingredients can compete on technical value, not just origin.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Tech Network South Africa

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Network South Africa

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.